Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Allergan, Inc.    AGN   US0184901025

ALLERGAN, INC. (AGN)

29
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

Allergan, Inc. : Allergan Gets Subpoena From Government Over Lap-Band System

05/07/2012 | 06:11pm US/Eastern
Recommend:
0
   By Anjali Athavaley 
   Of  
 

Allergan Inc. (AGN) received a subpoena this month from the Department of Health and Human Services requesting documents related to the company's Lap-Band System for obesity, according to a filing.

Lap-Band is approved to help obese patients lose weight. It is inserted surgically through a small incision and placed at the top of the stomach. The inflatable band can be tightened or loosened to reduce or enlarge stomach capacity.

An Allergan spokeswoman declined to comment further.

Earlier this month, Allergan said its first-quarter earnings rose 45% on double-digit sales growth in its specialty-pharmaceuticals business. But sales in Allergan's obesity intervention category slipped 15.5% as high unemployment, lofty co-payments and rigid requirements from insurers pressured sales.

Last December, the U.S. Food and Drug Administration warned nine groups, mostly surgical centers in California, that if they continue misleading advertising for Lap-Band, they could face monetary penalties and have inventory seized. The FDA made no allegations against Allergan at the time.

Allergan shares were up fractionally to $93.79 in after-hours trading Monday. The stock is up nearly 7% so far this year.

-By Anjali Athavaley, Dow Jones Newswires; 212-416-4912; anjali.athavaley@dowjones.com

Recommend :
0
React to this article
Latest news on ALLERGAN, INC.
1d ago ALLERGAN : "Modular Injection System and Method for Diluting an Injectable Fluid..
1d ago ALLERGAN : Assigned Patent
1d ago ALLERGAN : Maryland Laser Skin and Vein Receives Diamond Status From Allergan
1d ago ALLERGAN : "Cross-Linked Hyaluronic Acid and Collagen and Uses Thereof" in Paten..
2d ago WILLIAM ACKMAN : Valeant, Ackman get October 6 trial over Allergan special meeti..
2d ago ALLERGAN : Taps Jim Hindman as CFO
3d ago ALLERGAN : Facing shareholder demands, Allergan calls special meeting for Decemb..
3d ago ALLERGAN : to Request California Federal Court Block Valeant and Pershing Square..
3d ago ALLERGAN : Eyes INR10bn Revenues By Fiscal 2018 In India
3d ago ALLERGAN : Latisse.md Announces 5.5 Million Latisse Bottles Sold
Advertisement
Chart
Duration : Period :
Allergan, Inc. Technical Analysis Chart | AGN | US0184901025 | 4-Traders
Income Statement Evolution
Allergan, Inc. : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF